Anthropic files for IPO that could raise up to $100bn

Anthropic has filed papers for a Nasdaq listing under the ticker ANT, setting up a Wall Street debut next month that could raise as much as $100bn and eclipse the record $86bn SpaceX offering in June. The company was valued at $965bn by private investors earlier this year, with reports suggesting the IPO could lift that to $1.5tn or even $2tn.
The 335-page filing shows revenue of more than $16bn in the first half of the year, 14 times the same period a year earlier, though the Claude maker remains unprofitable. It reported a net loss of $80.7bn for the half, including a one-time $72.4bn accounting charge tied to financing agreements.
The document carries nearly 100 pages of risk factors, including the prospect of malicious actors using its models to build chemical weapons or AI going rogue and posing existential risks to humanity. A Long-Term Benefit Trust holds power to appoint directors, and the seven co-founders will control 50.1% of shareholder votes through a special share class.
Anthropic is also in dispute with the US government, which designated it a supply chain risk in February. The company sued the Pentagon in March and is appealing a mixed set of court rulings.